Cellular imaging in drug discovery (original) (raw)

• Hood, L. & Perlmutter, R. M. The impact of systems approaches on biological problems in drug discovery. Nature Biotechnol. 22, 1215–1217 (2004).
  Article CAS Google Scholar
• Sams-Dodd, F. Target-based drug discovery: is something wrong? Drug Discov. Today 10, 139–147 (2005).
  Article CAS PubMed Google Scholar
• Besson, D., Yeow, K., Lang, P. & Scheer, A. HTS and cellular biology at Serono. Curr. Drug Discov. 29–32 (2003).
• Comley, J. High content screening: emerging importance of novel reagents/probes and pathway analysis. Drug Discov. World 6, 31–54 (2005).
  Google Scholar
• Ramm, P. Image-based screening: a technology in transition. Curr. Opin. Biotechnol. 16, 41–48 (2005).This review describes the advantages and disadvantages of using cellular imaging technologies in screening, and provides clues of what future cellular imaging systems requirements are for HTS purposes.
  Article CAS PubMed Google Scholar
• Bivona, T. G. & Philips, M. R. Analysis of Ras and Rap activation in living cells using fluorescent Ras binding domains. Methods 37, 138–145 (2005).
  Article CAS PubMed Google Scholar
• Voss, T. C., Demarco, I. A. & Day, R. N. Quantitative imaging of protein interactions in the cell nucleus. Biotechniques 38, 413–424 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Sekar, R. B. & Periasamy, A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160, 629–633 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Errington, R. J. et al. Advanced microscopy solutions for monitoring the kinetics and dynamics of drug–DNA targeting in living cells. Adv. Drug Deliv. Rev. 57, 153–167 (2005).
  Article CAS PubMed Google Scholar
• von Arnim, C. A. et al. The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate. J. Biol. Chem. 280, 17777–17785 (2005).
  Article CAS PubMed Google Scholar
• Herzenberg, L. A. et al. The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. Clin. Chem. 48, 1819–1827 (2002).
  CAS PubMed Google Scholar
• Geuijen, C. A. et al. Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery. J. Immunol. Methods 302, 68–77 (2005).
  Article CAS PubMed Google Scholar
• Florian, S. et al. Detection of molecular targets on the surface of CD34+/CD38– stem cells in various myeloid malignancies. Leuk. Lymphoma 47, 207–222 (2006).
  Article CAS PubMed Google Scholar
• Heinemann, A. et al. Basophil responses to chemokines are regulated by both sequential and cooperative receptor signaling. J. Immunol. 165, 7224–7233 (2000).
  Article CAS PubMed Google Scholar
• Tanaka, M. et al. An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol. 3, e128 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Miller, S. C. & Mitchison, T. J. Synthesis and phenotypic screening of a guanine-mimetic library. Chembiochem. 5, 1010–1012 (2004).
  Article CAS PubMed Google Scholar
• Yarrow, J. C., Feng, Y., Perlman, Z. E., Kirchhausen, T. & Mitchison, T. J. Phenotypic screening of small molecule libraries by high throughput cell imaging. Comb. Chem. High Throughput. Screen. 6, 279–286 (2003).Highlights the power of cellular imaging in finding active small molecules and shows how compound progression can be carried out to find the molecular target affecting cellular phenotype.
  Article CAS PubMed Google Scholar
• Yarrow, J. C., Totsukawa, G., Charras, G. T. & Mitchison, T. J. Screening for cell migration inhibitors via automated microscopy reveals a Rho-kinase inhibitor. Chem. Biol. 12, 385–395 (2005).
  Article CAS PubMed Google Scholar
• Ramm, P. et al. Automated screening of neurite outgrowth. J. Biomol. Screen. 8, 7–18 (2003).
  Article PubMed Google Scholar
• Richards, G. R., Millard, R. M., Leveridge, M., Kerby, J. & Simpson, P. B. Quantitative assays of chemotaxis and chemokinesis for human neural cells. Assay. Drug Dev. Technol. 2, 465–472 (2004).
  Article CAS PubMed Google Scholar
• Bahnson, A. et al. Automated measurement of cell motility and proliferation. BMC Cell Biol. 6, 19 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Berns, K. et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431–437 (2004).
  Article CAS PubMed Google Scholar
• Eggert, U. S. et al. Parallel chemical genetic and genome-wide RNAi screens identify cytokinesis inhibitors and targets. PLoS Biol. 2, e379 (2004).
  Article PubMed PubMed Central Google Scholar
• Mattheakis, L. C. et al. Optical coding of mammalian cells using semiconductor quantum dots. Anal. Biochem. 327, 200–208 (2004).
  Article CAS PubMed Google Scholar
• Edwards, B. S., Oprea, T., Prossnitz, E. R. & Sklar, L. A. Flow cytometry for high-throughput, high-content screening. Curr. Opin. Chem. Biol. 8, 392–398 (2004).
  Article CAS PubMed Google Scholar
• Irish, J. M. et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118, 217–228 (2004).An impressive paper demonstrating how flow cytometry using antiphospho antibodies can provide new ways of clustering cancer-patient populations according to signalling pathways.
  Article CAS PubMed Google Scholar
• Morgan, E. et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110, 252–266 (2004).
  Article CAS PubMed Google Scholar
• Wong, C. K., Cheung, P. F., Ip, W. K. & Lam, C. W. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-κB. Am. J. Respir. Cell Mol. Biol. 33, 186–194 (2005).
  Article CAS PubMed Google Scholar
• Rausch, O. Use of high-content analysis for compound screening and target selection. IDrugs 8, 573–577 (2005).
  CAS PubMed Google Scholar
• Ramm, P. Imaging systems in assay screening. Drug Discov. Today 4, 401–410 (1999).
  Article CAS PubMed Google Scholar
• Wu, C. C., Reilly, J. F., Young, W. G., Morrison, J. H. & Bloom, F. E. High-throughput morphometric analysis of individual neurons. Cereb. Cortex 14, 543–554 (2004).
  Article PubMed Google Scholar
• Burnett, P. et al. Fluorescence imaging of electrically stimulated cells. J. Biomol. Screen. 8, 660–667 (2003).
  Article CAS PubMed Google Scholar
• Ramm, P. Advanced image analysis systems in cell, molecular and neurobiology applications. J. Neurosci. Methods 54, 131–149 (1994).
  Article CAS PubMed Google Scholar
• Takahashi, Y., Sawada, R., Ishibashi, K., Mikuni, S. & Kinjo, M. Analysis of cellular functions by multipoint fluorescence correlation spectroscopy. Curr. Pharm. Biotechnol. 6, 159–165 (2005).
  Article CAS PubMed Google Scholar
• Wouters, F. S., Verveer, P. J. & Bastiaens, P. I. Imaging biochemistry inside cells. Trends Cell Biol. 11, 203–211 (2001).
  Article CAS PubMed Google Scholar
• Watson, P., Jones, A. T. & Stephens, D. J. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Adv. Drug Deliv. Rev. 57, 43–61 (2005).
  Article CAS PubMed Google Scholar
• Gasparri, F., Mariani, M., Sola, F. & Galvani, A. Quantification of the proliferation index of human dermal fibroblast cultures with the ArrayScan high-content screening reader. J. Biomol. Screen. 9, 232–243 (2004).
  Article CAS PubMed Google Scholar
• Schroeder, K. S. & Neagle, B. D. FLIPR: a new instrument for accurate, high throughput optical screening. J. Biomol. Screen. 1, 75–80 (1996).Describes the first application of a fluorometric imaging plate reader (FLIPR), one of the most widely adopted cellular imaging tools in the pharmaceutical industry so far.
  Article CAS Google Scholar
• Reynen, P. H., Martin, G. R., Eglen, R. M. & MacLennan, S. J. Characterization of human recombinant α2A-adrenoceptors expressed in Chinese hamster lung cells using intracellular Ca2+ changes: evidence for cross-talk between recombinant α2A- and native α1-adrenoceptors. Br. J. Pharmacol. 129, 1339–1346 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Nickolls, S. A., Fleck, B., Hoare, S. R. & Maki, R. A. Functional selectivity of melanocortin 4 receptor peptide and nonpeptide agonists: evidence for ligand-specific conformational states. J. Pharmacol. Exp. Ther. 313, 1281–1288 (2005).
  Article CAS PubMed Google Scholar
• Gopalakrishnan, S. M. et al. An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR. J. Biomol. Screen. 10, 46–55 (2005).
  Article CAS PubMed Google Scholar
• Patel, K. et al. Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells. Eur. J. Pharmacol. 430, 203–210 (2001).
  Article CAS PubMed Google Scholar
• Benjamin, E. R. et al. State-dependent compound inhibition of Nav1.2 sodium channels using the FLIPR Vm dye: on-target and off-target effects of diverse pharma-cological agents. J. Biomol. Screen. 11, 29–39 (2005).
  Article CAS PubMed Google Scholar
• Benjamin, E. R. et al. Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators. J. Biomol. Screen. 10, 365–373 (2005).
  Article CAS PubMed Google Scholar
• Giuliano, K. A. & Taylor, D. L. Fluorescent-protein biosensors: new tools for drug discovery. Trends Biotechnol. 16, 135–140 (1998).
  Article CAS PubMed Google Scholar
• Ghosh, R. N., Grove, L. & Lapets, O. A quantitative cell-based high-content screening assay for the epidermal growth factor receptor-specific activation of mitogen-activated protein kinase. Assay. Drug Dev. Technol. 2, 473–481 (2004).
  Article CAS PubMed Google Scholar
• Kapur, R. Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. Ann. NY Acad. Sci. 961, 196–197 (2002).
  Article PubMed Google Scholar
• Grepin, C. et al. Increasing the quality of compounds isolated during primary screening: high content screening with Acumen Explorer. Curr. Drug Discov. 3, 37–42 (2003).
  Google Scholar
• Jager, S. et al. A modular, fully integrated ultra-high-throughput screening system based on confocal fluorescence analysis techniques. J. Biomol. Screen. 8, 648–659 (2003).
  Article CAS PubMed Google Scholar
• Oakley, R. H. et al. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay. Drug Dev. Technol. 1, 21–30 (2002).
  Article CAS PubMed Google Scholar
• Fowler, A., Davies, I. & Norey, C. A multi-modality assay platform for ultra-high throughput screening. Curr. Pharm. Biotechnol. 1, 265–281 (2000).
  Article CAS PubMed Google Scholar
• Almholt, D. L. et al. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. Assay. Drug Dev. Technol. 2, 7–20 (2004).
  Article CAS PubMed Google Scholar
• Almholt, K. et al. Changes in intracellular cAMP reported by a redistribution assay using a cAMP-dependent protein kinase-green fluorescent protein chimera. Cell Signal. 16, 907–920 (2004).
  Article CAS PubMed Google Scholar
• Bertelsen, M. & Sanfridson, A. Inflammatory pathway analysis using a high content screening platform. Assay. Drug Dev. Technol. 3, 261–271 (2005).Describes the application of cellular imaging to compound profiling by monitoring its efficacy across various signalling pathways.
  Article CAS PubMed Google Scholar
• Li, Z. et al. Identification of gap junction blockers using automated fluorescence microscopy imaging. J. Biomol. Screen. 8, 489–499 (2003).
  Article CAS PubMed Google Scholar
• Lundholt, B. K. et al. Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer. J. Biomol. Screen. 10, 20–29 (2005).Describes the use of a HT cellular imaging device to screen compounds and a high-content screening cellular imaging platform to understand the mode of action of a compound.
  Article CAS PubMed Google Scholar
• Borchert, K. M. et al. High-content screening assay for activators of the Wnt/Fzd pathway in primary human cells. Assay. Drug Dev. Technol. 3, 133–141 (2005).
  Article CAS PubMed Google Scholar
• Horrocks, C., Halse, R., Suzuki, R. & Shepherd, P. R. Human cell systems for drug discovery. Curr. Opin. Drug Discov. Devel. 6, 570–575 (2003).
  CAS PubMed Google Scholar
• Obinata, M. Possible applications of conditionally immortalized tissue cell lines with differentiation functions. Biochem. Biophys. Res. Commun. 286, 667–672 (2001).
  Article CAS PubMed Google Scholar
• McNeish, J. Embryonic stem cells in drug discovery. Nature Rev. Drug Discov. 3, 70–80 (2004).This review highlights the potential power of using stem cells in target discovery and primary screening.
  Article CAS Google Scholar
• Allen, M. et al. Deficiency of the stress kinase p38α results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J. Exp. Med. 191, 859–870 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Levenberg, S., Golub, J. S., Amit, M., Itskovitz-Eldor, J. & Langer, R. Endothelial cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA 99, 4391–4396 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Trounson, A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 24 Jan 2006 [epub ahead of print].
  Google Scholar
• Laschinski, G., Vogel, R. & Spielmann, H. Cytotoxicity test using blastocyst-derived euploid embryonal stem cells: a new approach to in vitro teratogenesis screening. Reprod. Toxicol. 5, 57–64 (1991).
  Article CAS PubMed Google Scholar
• Mitchell, K. E. et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21, 50–60 (2003).
  Article CAS PubMed Google Scholar
• Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–715 (2004).
  Article CAS Google Scholar
• Ulrich, R. & Friend, S. H. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nature Rev. Drug Discov. 1, 84–88 (2002).
  Article CAS Google Scholar
• Smith, D. A. & van de, W. H. Pharmacokinetics and metabolism in early drug discovery. Curr. Opin. Chem. Biol. 3, 373–378 (1999).
  Article CAS PubMed Google Scholar
• Waters, M. D. & Fostel, J. M. Toxicogenomics and systems toxicology: aims and prospects. Nature Rev. Genet. 5, 936–948 (2004).
  Article CAS PubMed Google Scholar
• Riley, R. J. & Kenna, J. G. Cellular models for ADMET predictions and evaluation of drug–drug interactions. Curr. Opin. Drug Discov. Dev. 7, 86–99 (2004).
  CAS Google Scholar
• Nersesyan, K., Melikyan, G. S. & Stopper, H. Genotoxic activity of newly synthesized derivatives of cyano-pyridone in murine cells in vivo and in vitro. Tsitol. Genet. 38, 44–48 (2004).
  CAS PubMed Google Scholar
• Tice, R. R. et al. Report from the working group on the in vivo mammalian bone marrow chromosomal aberration test. Mutat. Res. 312, 305–312 (1994).
  Article CAS PubMed Google Scholar
• Fenech, M. In vitro micronucleus technique to predict chemosensitivity. Methods Mol. Med. 111, 3–32 (2005).
  PubMed Google Scholar
• Fenech, M. The cytokinesis-block micronucleus technique and its application to genotoxicity studies in human populations. Environ. Health Perspect. 101 (Suppl. 3), 101–107 (1993).
  CAS PubMed PubMed Central Google Scholar
• Ekins, S., Nikolsky, Y. & Nikolskaya, T. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity. Trends Pharmacol. Sci. 26, 202–209 (2005).
  Article CAS PubMed Google Scholar
• Pritchard, J. F. et al. Making better drugs: decision gates in non-clinical drug development. Nature Rev. Drug Discov. 2, 542–553 (2003).
  Article CAS Google Scholar
• Lesko, L. J. & Atkinson, A. J. Jr. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu. Rev. Pharmacol. Toxicol. 41, 347–366 (2001).
  Article CAS PubMed Google Scholar
• Frank, R. & Hargreaves, R. Clinical biomarkers in drug discovery and development. Nature Rev. Drug Discov. 2, 566–580 (2003).
  Article CAS Google Scholar
• De Meyer, G. & Shapiro, F. Biomarker development:the road to clinical utility. Curr. Drug Discov. 12, 23–37 (2003).
  Google Scholar
• Rolan, P., Atkinson, A. J. Jr & Lesko, L. J. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Clin. Pharmacol. Ther. 73, 284–291 (2003).
  Article PubMed Google Scholar
• Koop, R. Combinatorial biomarkers: from early toxicology assays to patient population profiling. Drug Discov. Today 10, 781–788 (2005).
  Article CAS PubMed Google Scholar
• Nishimura, T. et al. Disease proteomics toward bedside reality. J. Gastroenterol. 40 (Suppl. 16), 7–13 (2005).
  Article CAS PubMed Google Scholar
• Liu, E. T. Expression genomics and drug development: towards predictive pharmacology. Brief. Funct. Genomic. Proteomic. 3, 303–321 (2005).
  Article PubMed Google Scholar
• Shibazaki, M., Takeuchi, T., Ahmed, S. & Kikuchia, H. Blockade by SB203580 of Cyp1a1 induction by 2,3, 7,8-tetrachlorodibenzo-_p_-dioxin, and the possible mechanism: possible involvement of the p38 mitogen-activated protein kinase pathway in shuttling of Ah receptor overexpressed in COS-7 cells. Ann. NY Acad. Sci. 1030, 275–281 (2004).
  Article CAS PubMed Google Scholar
• Traxler, P. et al. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity. Cancer Res. 64, 4931–4941 (2004).
  Article CAS PubMed Google Scholar
• Koga, H. et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J. Am. Coll. Cardiol. 45, 1622–1630 (2005).
  Article CAS PubMed Google Scholar
• Bick, R. J. et al. Fluorescence imaging microscopy of cellular markers in ischemic vs non-ischemic cardiomyopathy after left ventricular unloading. J. Heart Lung Transplant. 24, 454–461 (2005).
  Article PubMed Google Scholar
• Kelloff, G. J. & Sigman, C. C. New science-based endpoints to accelerate oncology drug development. Eur. J. Cancer 41, 491–501 (2005).
  Article PubMed Google Scholar
• Swanson, B. N. Delivery of high-quality biomarker assays. Dis. Markers 18, 47–56 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Colburn, W. A. Biomarkers in drug discovery and development: from target identification through drug marketing. J. Clin. Pharmacol. 43, 329–341 (2003).
  Article PubMed Google Scholar
• Rathbun, R. C. Surrogate markers for assessing treatment response in HIV disease. Ann. Pharmacother. 27, 450–455 (1993).Demonstrates how cellular imaging can be used in the field of clinical biomarkers by monitoring CD4 cell count in patients with HIV.
  Article CAS PubMed Google Scholar
• Perlman, Z. E. et al. Multidimensional drug profiling by automated microscopy. Science 306, 1194–1198 (2004).A study that demonstrates the power of cell systems tools when combined with cellular imaging to profile drugs and understand their mechanism of action.
  Article CAS PubMed Google Scholar
• Nolan, J. P., Lauer, S., Prossnitz, E. R. & Sklar, L. A. Flow cytometry: a versatile tool for all phases of drug discovery. Drug Discov. Today 4, 173–180 (1999).
  Article CAS PubMed Google Scholar
• Asadullah, K., Sterry, W. & Volk, H. D. Analysis of cytokine expression in dermatology. Arch. Dermatol. 138, 1189–1196 (2002).
  Article CAS PubMed Google Scholar
• Duramad, P., McMahon, C. W., Hubbard, A., Eskenazi, B. & Holland, N. T. Flow cytometric detection of intracellular TH1/TH2 cytokines using whole blood: validation of immunologic biomarker for use in epidemiologic studies. Cancer Epidemiol. Biomarkers Prev. 13, 1452–1458 (2004).
  CAS PubMed Google Scholar
• de Weck, A. L. et al. Lymphocyte proliferation, lymphokine production, and lymphocyte receptors in ageing and various clinical conditions. Springer Semin. Immunopathol. 7, 273–289 (1984).
  Article CAS PubMed Google Scholar
• Lacombe, F. & Belloc, F. Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia. Hematol. Cell Ther. 38, 495–504 (1996).
  Article CAS PubMed Google Scholar
• Krutzik, P. O., Irish, J. M., Nolan, G. P. & Perez, O. D. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol. 110, 206–221 (2004).
  Article CAS PubMed Google Scholar
• Medintz, I. L., Uyeda, H. T., Goldman, E. R. & Mattoussi, H. Quantum dot bioconjugates for imaging, labelling and sensing. Nature Mater. 4, 435–446 (2005).
  Article CAS Google Scholar
• Rubart, M. Two-photon microscopy of cells and tissue. Circ. Res. 95, 1154–1166 (2004).
  Article CAS PubMed Google Scholar
• Paris, S. & Sesboue, R. Metastasis models: the green fluorescent revolution? Carcinogenesis 25, 2285–2292 (2004).
  Article CAS PubMed Google Scholar
• Chishima, T. et al. Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res. 57, 2042–2047 (1997).
  CAS PubMed Google Scholar
• Kan, Z. & Liu, T. J. Video microscopy of tumor metastasis: using the green fluorescent protein (GFP) gene as a cancer-cell-labeling system. Clin. Exp. Metastasis 17, 49–55 (1999).
  Article CAS PubMed Google Scholar
• Rice, B. W., Cable, M. D. & Nelson, M. B. In vivo imaging of light-emitting probes. J. Biomed. Opt. 6, 432–440 (2001).
  Article CAS PubMed Google Scholar
• Uhrbom, L., Nerio, E. & Holland, E. C. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nature Med. 10, 1257–1260 (2004).
  Article CAS PubMed Google Scholar
• Kumar, S., Kahn, M. A., Dinh, L. & de Vellis, J. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J. Neurosci. Res. 54, 754–765 (1998).
  Article CAS PubMed Google Scholar
• Gao, X. et al. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16, 63–72 (2005).
  Article CAS PubMed Google Scholar
• Michalet, X. et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538–544 (2005).Illustrates the potential of quantum dot beads to track cell fate in vivo , and exemplifies the possibility of multiplexing cellular imaging technology.
  Article CAS PubMed PubMed Central Google Scholar
• Fischer, H. P. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol. Annu. Rev. 11, 1–68 (2005).
  Article CAS PubMed Google Scholar
• Butcher, E. C. Can cell systems biology rescue drug discovery? Nature Rev. Drug Discov. 4, 461–467 (2005).
  Article CAS Google Scholar
• Sachs, K., Perez, O., Pe'er, D., Lauffenburger, D. A. & Nolan, G. P. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308, 523–529 (2005).
  Article CAS PubMed Google Scholar
• Miyawaki, A., Sawano, A. & Kogure, T. Lighting up cells: labelling proteins with fluorophores. Nature Cell Biol. (Suppl.), S1–S7 (2003).
• Zhang, J., Campbell, R. E., Ting, A. Y. & Tsien, R. Y. Creating new fluorescent probes for cell biology. Nature Rev. Mol. Cell Biol. 3, 906–918 (2002).
  Article CAS Google Scholar
• Verkhusha, V. V. & Lukyanov, K. A. The molecular properties and applications of Anthozoa fluorescent proteins and chromoproteins. Nature Biotechnol. 22, 289–296 (2004).
  Article CAS Google Scholar
• Lukyanov, K. A., Chudakov, D. M., Lukyanov, S. & Verkhusha, V. V. Innovation: photoactivatable fluorescent proteins. Nature Rev. Mol. Cell Biol. 6, 885–891 (2005).
  Article CAS Google Scholar
• Hercend, T. et al. Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinoma. J. Biol. Response Mod. 9, 546–555 (1990).
  CAS PubMed Google Scholar
• Nagy, R. D. et al. Stem cell transplantation as a therapeutic approach to organ failure. J. Surg. Res. 129, 152–160 (2005).
  Article CAS PubMed Google Scholar
• Nir, T. & Dor, Y. How to make pancreatic β cells — prospects for cell therapy in diabetes. Curr. Opin. Biotechnol. 16, 524–529 (2005).
  Article CAS PubMed Google Scholar
• Keller, G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19, 1129–1155 (2005).
  Article CAS PubMed Google Scholar
• Wollert, K. C. et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364, 141–148 (2004).
  Article PubMed Google Scholar
• Tang, Y. L. Cellular therapy with autologous skeletal myoblasts for ischemic heart disease and heart failure. Methods Mol. Med. 112, 193–204 (2005).
  PubMed Google Scholar
• Sykes, M. & Nikolic, B. Treatment of severe autoimmune disease by stem-cell transplantation. Nature 435, 620–627 (2005).
  Article CAS PubMed Google Scholar
• Radbruch, A. & Thiel, A. Cell therapy for autoimmune diseases: does it have a future? Ann. Rheum. Dis. 63 (Suppl. 2), ii96–ii101 (2004).
  CAS PubMed PubMed Central Google Scholar
• Mattson, M. P. Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp. Gerontol. 35, 489–502 (2000).
  Article CAS PubMed Google Scholar
• Tuszynski, M. H. et al. A Phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature Med. 11, 551–555 (2005).
  Article CAS PubMed Google Scholar
• Brundin, P. et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123, 1380–1390 (2000).
  Article PubMed Google Scholar
• Widner, H. et al. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N. Engl. J. Med. 327, 1556–1563 (1992).
  Article CAS PubMed Google Scholar
• Bulte, J. W. Hot spot MRI emerges from the back-ground. Nature Biotechnol. 23, 945–946 (2005).
  Article CAS Google Scholar
• Eriksson, P. S. et al. Neurogenesis in the adult human hippocampus. Nature Med. 4, 1313–1317 (1998).
  Article CAS PubMed Google Scholar
• Zhu, J., Wu, X. & Zhang, H. L. Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation. Curr. Drug Targets 6, 97–110 (2005).
  Article CAS PubMed Google Scholar
• Frangioni, J. V. & Hajjar, R. J. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110, 3378–3383 (2004).
  Article PubMed Google Scholar
• Vogt, A. et al. Cell-active dual specificity phosphatase inhibitors identified by high-content screening. Chem. Biol. 10, 733–742 (2003).
  Article CAS PubMed Google Scholar
• DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003).
  Article PubMed Google Scholar